Targeting Early Extracellular Matrix Abnormalities to Treat Cardiac Insulin Resistance and Associated Dysfunction (Joint with University of Glasgow)

StatusActive
Effective start/end date6/03/195/03/22

Funding

  • British Heart Foundation (PG/18/56/33935): £295,241.00